If you’re new to weight loss treatments and want to learn more about them, we’re here to help.
Tablets like (the brand name for Orlistat) work by reducing the amount of fat your body absorbs. Ordinarily, fats are broken down during the digestion process by enzymes called lipases. Xenical prevents these enzymes from working effectively, limiting how much fat your body is able to absorb. The remaining, undigested fat is then excreted.
In contrast to Xenical, weight loss injections (or pens) work by suppressing your appetite - particularly your appetite for fatty foods. Some weight loss injections also slow the digestion process down, making you feel fuller for longer. They’re simple to use - check out our for more information.
Clinical trials have repeatedly demonstrated the effectiveness of both weight loss tablets and injections, particularly in combination with a healthy diet and lifestyle., participants using lost almost 15% of their body weight over a 15-month period.
Starting your weight loss journey is simple with IQ Doctor. To begin, click on a product and then hit the 'Start Consultation' button. The online consultation process is quick, simple and free; just complete the form and we’ll verify whether the medication is suitable for you or not. If it is, you can then place your order and receive it the very next day.
Send questions for more information about weight lossThe most common side effects of Orlistat are nausea, abdominal pain, and diarrhea. Most people do not experience any side effects at all. If you think you’re having an side effect, you should consult with your healthcare professional or pharmacist. They may suggest additional weight loss medications or supplements that are not recommended. Click on the Patient Information Leaflet that will take you to the fine details that are necessary for your to be prescribed the drug.
If you stop taking Orlistat within the first 6 months of stopping therapy, you should stop taking the drug as well. However, because the drug stops the absorption of fat, you’ll need to stop taking the drug as well. The 6-month medication adjustment period will determine which medication is suitable for you.
If you are gaining 30% of your weight within the first 6 months of taking Orlistat, you should not use this medication. Although the drug does not cause physical to weight gain, it can cause serious psychological problems for those affected. For example, if you have a history of heart problems or high blood pressure, or a history of lactic acidosis? If you are a woman, you may lose 30% of your weight over the past 6 months. There is a possible risk of psychological problems if you use orlistat for a longer duration of time. For example, if you have psychological problems such, for you the risk of gaining 30% of your weight over the 6 months of taking Orlistat should be considered.
This medication works by in three main mechanisms. First, it blocks enzymes that are involved in breaking down fats during the digestion process. These enzymes hydrolyse the fat and subsequently assist in breaking down some of the sugar found in fats. This prevents enzymes from breaking down fat, which is then excreted. However, because Orlistat stops fat absorption, you’ll need to stop taking the drug as well. The other in which Orlistat is applied is suppressive - where the medication suppress natural weight loss by inhibiting the absorption of food rather than limiting it. Suppressive medication is usually used in combination with a healthy diet and regular physical exercise.
The most common side effects of Orlistat are constipation, indigestion, and heartburn. The constipation most frequently is painful, so you should always consult with your healthcare professional or pharmacist. The indigestion most frequently is heartburn that occurs less than a two week period after taking Orlistat. The most frequent side effects are diarrhea, and back pain. Back pain can make you feel dizzy or nauseous.
Obesityis a growing concern. As the prevalence of obesity increases, the need for effective dietary management becomes an increasing demand. The World Health Organization (WHO) has identified an increase in obesity rates in both sexes and in age groups, and it is estimated that more than one-third of all adults between the ages of 25 and 34 in the world may be obese. This condition can be classified as a chronic condition that can lead to health problems, including heart disease, blood pressure, diabetes, and cardiovascular diseases, and treatment can be provided if it is necessary.
Obesity is a growing public health concern, and obesity can be a significant risk factor for many people. The World Health Organization estimates that about 1.2 billion people in the world are obese. Obesity is a serious problem, and it can increase the risk of heart disease, diabetes, and high blood pressure. More than one-third of people who have an obesity-related condition are underweight. The prevalence of obesity has been rising, and it is estimated that more than one-third of people who have an obesity-related condition are underweight.
A variety of medications are available to help manage obesity. One medication that has been used by millions of people worldwide is orlistat. Orlistat is an orlistat that is administered to a patient by a physician to assist in the weight management of a patient with obesity. Orlistat works by blocking the absorption of fat from the food that is produced from a person's diet, and is used to help reduce the risk of developing type 2 diabetes. Another medication that has been used by millions of people worldwide is orlistat. Orlistat is a prescription medication that is taken by mouth to treat the symptoms of an obesity-related condition. Orlistat is available in a variety of forms, including tablets, capsules, and oral suspension. Orlistat is available in two different forms, as a liquid capsule, a tablet, a suspension, and a chewable tablet. The most common form of orlistat is the immediate-release formulation. The immediate-release formulation is manufactured by Novartis Pharmaceuticals and comes in three forms, the immediate-release tablet, the extended-release capsule, and the chewable tablet. The extended-release form is manufactured by a pharmaceutical company called Merck & Co., and the combination of the two forms is called the extended-release form.
The use of oral contraceptives has been associated with an increased risk of certain cancers in women. In addition, the use of orlistat is associated with an increased risk of blood clots, and an increased risk of stroke, and a higher risk of diabetes. A meta-analysis found that orlistat may be associated with an increased risk of heart disease and blood vessel problems in patients with diabetes, such as those who are overweight or obese. Other studies have also shown that orlistat can increase the risk of some cancers. A study published in the January 2010 edition of the JAMA Dermatol Therapeutics found that orlistat had an increased risk of breast cancer in patients with diabetes. A recent study published in the April 2011 issue of the Journal of Clinical Oncology found that orlistat was not associated with a higher risk of invasive breast cancer in a randomized trial of patients who were treated with either a placebo or a drug that was taken at a higher dose. The risk of breast cancer increases by about one-quarter with orlistat treatment. There are some studies that have shown that orlistat may increase the risk of heart disease and blood vessel problems in patients with diabetes, including those who are overweight or obese.
A study published in the April 2011 issue of the Journal of Clinical Oncology found that orlistat may be associated with an increased risk of certain cancers in patients with diabetes, such as those who are overweight or obese. Other studies have also found that orlistat can increase the risk of certain cancers, such as blood clots, breast cancer, and a rare type of cancer called ductal carcinoma in situ (DCIS). An increased risk of breast cancer has also been reported in patients taking orlistat, and a risk increase with orlistat treatment has been observed in patients taking a combination of the two medications.
A study published in the May 2010 edition of the Journal of Clinical Oncology found that orlistat may be associated with an increased risk of certain cancers, including blood clots and breast cancer. The risk increases with higher doses and a higher risk of blood clots. The increased risk of blood clots may be associated with higher doses of orlistat and an increased risk of breast cancer.
A study published in the May 2011 issue of the Journal of Clinical Oncology found that orlistat may be associated with an increased risk of certain cancers, including blood clots and breast cancer.
Orlistat is used to treat obesity and help in weight loss. Orlistat is to be used along with a low-calorie diet and regular physical exercise. Obesity is a common condition associated with excessive body fat, which in turn increases the risk of other health problems such as diabetes, high blood pressure, certain cancers, and heart disease. Intake of more calories than you burn by exercise or daily activities results in obesity.
Orlistat contains Orlistat, which works in the small intestine and stomach and prevents the action of enzymes that break down fat, which is absorbed by the body. Orlistat decreases the absorption of fat from the food you eat. Thus, fat passes through the gut and is excreted in the faeces, which makes the body unable to use fat as a source of energy or convert it into fat tissue. Thereby, Orlistat helps in weight loss.
Take Orlistat as prescribed by your doctor. You are advised to take Orlistat for as long as your doctor has prescribed it for you based on your medical condition. Some people may experience soft stools, sudden bowel motions, flatulence (gas) with or without oily spotting, oily or fatty stools, stomach pain, stool incontinence (involuntary leakage of stools), and runny or liquid stools. Most of these side effects of Orlistat do not require medical attention and gradually resolve over time. However, if the side effects persist, please consult your doctor.
If you are allergic to Orlistat or any other medicines, please tell your doctor. Avoid taking Orlistat if you are pregnant or planning for pregnancy, as it may cause fetal harm. It is not known whether Orlistat is excreted in human milk. Therefore, please consult a doctor if you are a breastfeeding woman. Orlistat is not recommended for children below 18 years of age, as the safety and effectiveness were not established. You are advised to take a multivitamin containing fat-soluble vitamins such as A, D, E, and K at bedtime as Orlistat may reduce the absorption of certain vitamins in the body.
ContraindicationsOrlistat is not recommended for use in patients with a history of seizures, kidney problems, or those with severe liver disease. Also not recommended for use in patients who have recently had cardiac surgery. Patients with a known hypersensitivity to Orlistat or any of the excipients: Placebo- or Orlistat-Contraindicated. Patients with significant gastrointestinal (peptic) problems (peptic ulcer, gastric or duodenal bleeding, or other intestinal diseases). Patients with a known or suspected allergy to Orlistat or any of the excipients: Placebo- or Orlistat-Contraindicated. Patients with a history of bladder cancer, or those taking NSAIDs, including Orlistat, for heart problems. Patients with a history of blood clots, or those taking blood thinners such as warfarin. Patients with a history of liver disease. Patients with a history of myocardial infarction or stroke. Patients with a known history of ovarian cysts. Patients with a known or suspected allergic reaction to Orlistat or any of the excipients: Placebo- or Orlistat-Contraindicated. Patients with a known history of kidney problems. Patients with a known or suspected alcohol/food allergy. Patients with a known or suspected bladder infection. Patients with a known or suspected head trauma. Patients with a known or suspected glaucoma. Patients with a known or suspected of having a heart attack, or if a heart attack or stroke occurs. Patients with a known or suspected of having a breast cancer or other cancer. Patients with a known or suspected of having a bleeding disorder. Patients with a known or suspected of having or had a bone marrow transplant. Patients with a known or suspected or claimed to have a history of liver disease. Patients with a known or suspected hereditary angioedema. Patients with a known or suspected of having a history of asthma. Patients with a known or suspected of having a history of blood clots. Patients with a known or suspected of being dependent on Orlistat. Patients with a known or suspected of being pregnant. Patients with vomiting. Patients with severe liver disease. Patients with a history of seizures. Patients with a known or suspected of having a history of bleeding or blood clotting disorders.
The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser.For the best experience on our site, be sure to turn on Javascript in your browser.
We must add new items to the cart
1. A new account is launched with yourold account now unavailable.
2. A new one is added to the user’s profile on our website.
3. A new product is added to the cart with thenew product inserted in it.
4. A new payment is added to the user’s payment cart with the old existing product.
5. A new photo is added to the cart with the new existing image.
6. The user can choose between three answers to a simpleuxquickie questions
“Can you get a prescription for Orlistat 60MG 60”
“Orlistat 60MG 60 is the best weight-loss drug”
The user can choose between three answers to a simpleuxquickone questions